Cargando…

HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research

A large body of research examines the relationship between HIV and drug dependence, but considerably less information is available on viral hepatitis and drug dependence. This article summarizes research indicating what drug abuse treatment programs can do to prevent their patients from acquiring HI...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorensen, James L., Masson, Carmen L., Perlman, David C.
Formato: Texto
Lenguaje:English
Publicado: National Institute on Drug Abuse 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851052/
https://www.ncbi.nlm.nih.gov/pubmed/18567957
_version_ 1782179845338300416
author Sorensen, James L.
Masson, Carmen L.
Perlman, David C.
author_facet Sorensen, James L.
Masson, Carmen L.
Perlman, David C.
author_sort Sorensen, James L.
collection PubMed
description A large body of research examines the relationship between HIV and drug dependence, but considerably less information is available on viral hepatitis and drug dependence. This article summarizes research indicating what drug abuse treatment programs can do to prevent their patients from acquiring HIV or hepatitis infection and to limit the consequences for patients who are already infected. Drug treatment programs can play a pivotal role in preventing, detecting, and treating HIV and hepatitis. Some activities can be accomplished by providers’ simply becoming aware of the issues; others will require significant infusion of leadership, education, and fiscal support.
format Text
id pubmed-2851052
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher National Institute on Drug Abuse
record_format MEDLINE/PubMed
spelling pubmed-28510522010-10-25 HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research Sorensen, James L. Masson, Carmen L. Perlman, David C. Sci Pract Perspect Research Review A large body of research examines the relationship between HIV and drug dependence, but considerably less information is available on viral hepatitis and drug dependence. This article summarizes research indicating what drug abuse treatment programs can do to prevent their patients from acquiring HIV or hepatitis infection and to limit the consequences for patients who are already infected. Drug treatment programs can play a pivotal role in preventing, detecting, and treating HIV and hepatitis. Some activities can be accomplished by providers’ simply becoming aware of the issues; others will require significant infusion of leadership, education, and fiscal support. National Institute on Drug Abuse 2002-07 /pmc/articles/PMC2851052/ /pubmed/18567957 Text en
spellingShingle Research Review
Sorensen, James L.
Masson, Carmen L.
Perlman, David C.
HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research
title HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research
title_full HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research
title_fullStr HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research
title_full_unstemmed HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research
title_short HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research
title_sort hiv/hepatitis prevention in drug abuse treatment programs: guidance from research
topic Research Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851052/
https://www.ncbi.nlm.nih.gov/pubmed/18567957
work_keys_str_mv AT sorensenjamesl hivhepatitispreventionindrugabusetreatmentprogramsguidancefromresearch
AT massoncarmenl hivhepatitispreventionindrugabusetreatmentprogramsguidancefromresearch
AT perlmandavidc hivhepatitispreventionindrugabusetreatmentprogramsguidancefromresearch